| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral administration | 5 |
22.7%
|
| 2 | Intravenous injection | 1 |
4.5%
|
| 3 | Topical Application | 0 |
0%
|
| 4 | Intramuscular injection | 16 |
72.7%
|
| 5 | Per Vagina | 0 |
0%
|
| Sysmiss | 6999 |